351 |
$RLFTF #TheMath GENEVA, Switzerland and RADNOR, |
mc67 |
02/06/2021 7:10:39 PM |
652 |
So mine showed today in Fidelity |
swordman |
05/08/2023 7:02:11 PM |
651 |
Never got my new shares? What is going |
Flash08 |
05/08/2023 12:42:06 PM |
650 |
Annual meeting shareholder results |
swordman |
04/28/2023 2:19:32 PM |
649 |
Relief Therapeutics Announces Positive 12-Month |
swordman |
04/27/2023 7:03:40 PM |
648 |
https://relieftherapeutics.com/newsblog-detail/?n |
swordman |
04/15/2023 12:49:15 AM |
646 |
Reverse split- 400-1 Thoughts? |
Flash08 |
04/04/2023 5:47:13 AM |
645 |
Looks like they can sell in the US. Great |
Flash08 |
02/28/2023 9:30:16 AM |
644 |
https://simplywall.st/stocks/ch/pharmaceuticals-b |
swordman |
02/16/2023 12:40:57 AM |
643 |
https://pharmaceutical-journal.com/article/featur |
swordman |
02/01/2023 11:16:05 PM |
642 |
Follow up to the use/approval in India |
swordman |
01/28/2023 2:19:34 PM |
641 |
https://relieftherapeutics.com/newsblog-detail/?n |
swordman |
01/28/2023 2:18:21 PM |
639 |
https://www.relieftherapeutics.com/newsblog-detai |
swordman |
01/18/2023 4:55:04 PM |
637 |
$RLFTF 27% v1,6M c.032975 f4,192B H.0338 |
znewcar1 |
11/07/2022 10:30:52 PM |
636 |
https://journals.lww.com/ccmjournal/Fulltext/2022 |
swordman |
10/14/2022 12:17:24 AM |
635 |
What is the expected market worldwide for this |
Flash08 |
10/12/2022 4:53:22 PM |
634 |
First sale of PKU Golike in the U.S. through |
swordman |
10/10/2022 1:42:54 AM |
633 |
https://medicaldialogues.in/critical-care/news/iv |
swordman |
09/30/2022 12:45:51 AM |
631 |
https://trialsjournal.biomedcentral.com/articles/ |
swordman |
09/21/2022 11:50:20 PM |
629 |
ACER gets orphan drug status |
swordman |
08/12/2022 3:51:56 PM |
627 |
https://pajhwok.com/ps/2022/06/26/physicians-opta |
swordman |
06/27/2022 12:59:19 AM |
624 |
Relief Therapeutics Expands U.S. Commercial Team |
swordman |
05/23/2022 2:29:15 AM |
623 |
Dr Harris asking Fauci to PLEASE get a |
swordman |
05/12/2022 1:48:21 AM |
621 |
Proven Pharmaceutical Marketing Leader Brings |
swordman |
04/26/2022 2:03:43 PM |
619 |
https://www.relieftherapeutics.com/newsblog-detai |
swordman |
04/12/2022 1:31:47 AM |
618 |
Relief Reports Full-Year 2021 Results and |
swordman |
03/31/2022 2:18:06 AM |
615 |
Preparing to Convert Relief's Level 1 American |
swordman |
03/21/2022 3:04:10 AM |
612 |
Dr story about being saved by Avip/Zyesami 2 |
swordman |
03/13/2022 7:57:13 PM |
611 |
ANOTHER article--getting traction |
swordman |
03/09/2022 11:52:58 PM |
610 |
Same story covered in Wisconsin Politics article |
swordman |
03/09/2022 8:04:44 PM |
609 |
Text of letter: March 3, 2022 Robert M. Califf, |
swordman |
03/08/2022 6:21:54 PM |
608 |
Congress asking about Aviptadil |
swordman |
03/08/2022 4:23:09 PM |
607 |
Trial update and presentation |
swordman |
03/01/2022 2:59:46 PM |
606 |
VERY detailed financial forecast of RLFT This is |
swordman |
02/21/2022 1:37:11 PM |
605 |
SYNAIRGEN --" did not meet its primary or key |
swordman |
02/21/2022 1:05:25 PM |
603 |
https://biobuzz.io/nrx-aims-to-bring-zyesami-to-m |
swordman |
02/14/2022 6:36:33 PM |
601 |
Lifesaving COVID Medications Can Be Hard to Come |
swordman |
02/13/2022 7:21:10 PM |